Endoscopy News and Research

RSS

Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Prime Healthcare announced today that it has completed its acquisition of two hospitals from subsidiaries of Community Health Systems: Dallas Regional Medical Center in Mesquite, Texas and Riverview Regional Medical Center in Gadsden, Alabama, as well as related outpatient services.

2 Mar 2015

ChartSpan Medical Technologies raises $1.7 million in capital round

ChartSpan Medical Technologies announced it has successfully raised a capital round of $1.7 million dollars. Since becoming the most downloaded iPhone and iPad medical app in the U.S. in December, ChartSpan continues to disrupt healthcare with innovative technology empowering patients to manage their own healthcare records and information.

27 Feb 2015

RD Biomed to launch reflux diagnostic study in China

RD Biomed, the Hull-based medical technology company, will launch a study with over 1,000 patients in China to measure the effectiveness of its reflux diagnostic device Peptest.

24 Feb 2015

GGEC opens new Endoscopy Center in Gastonia, NC

Four physicians, Sam Drake, MD; Bill Watkins, MD; Neville Forbes, MD; Austin Osemeka, MD and staff of the Greater Gaston Endoscopy Center (GGEC) joined by Physicians Endoscopy are pleased to announce the opening of their new Endoscopy Center in Gastonia, NC.

12 Feb 2015

New Endoscopic Technique

A flexible wide-field endoscope utilising blue excitation light provides label-free contrast of tissue based on fluorescence lifetime imaging of tissue autofluorescence.

10 Feb 2015

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

RTI Health Solutions, a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity.

2 Feb 2015

Novel technique could help identify cancerous tissue during brain tumor surgery

A novel radioguided surgery technique could quickly and effectively identify residual cancer cells during brain tumor surgery, with low radiation exposure for both patients and surgeons. The study, featured in the January 2015 issue of the Journal of Nuclear Medicine, reports that Y-90 DOTATOC, a beta-minus-emitting tracer, can effectively delineate the margins of meningiomas and high-grade gliomas.

28 Jan 2015

Mayo Clinic study dispels myth that cancer biopsies cause cancer to spread

A study of more than 2,000 patients by researchers at Mayo Clinic's campus in Jacksonville, Florida, has dispelled the myth that cancer biopsies cause cancer to spread. In the Jan. 9 online issue of Gut, they show that patients who received a biopsy had a better outcome and longer survival than patients who did not have a biopsy.

11 Jan 2015

Mayo Clinic researchers correctly evaluate polyps using high-definition optical lenses

It may not be necessary for experienced gastroenterologists to send polyps they remove from a patient's colon to a pathologist for examination, according to a large study conducted by physician researchers at the Jacksonville campus of Mayo Clinic.

19 Dec 2014

Olympus receives FDA clearance for Narrow Band Imaging

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today FDA 510(k) clearance of Narrow Band Imaging (NBI) as enabling effective targeting of biopsies not seen under white light and improved visualization of tumor boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients.

From Evident Corporation - Life Sciences 15 Dec 2014

Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

The American Gastroenterological Association Research Foundation is pleased to announce that Ashish Nimgaonkar, MBBS, MTech, MS, from John Hopkins University, has received the inaugural AGA-Boston Scientific Career Development Technology & Innovation Award. This award is graciously supported by a grant from Boston Scientific, a leading innovator of medical solutions.

5 Dec 2014

New light-triggered strategy can provide accurate control over aptamer-based therapeutics

While aptamers—single-stranded nucleic acids—offer promise as drug-delivery tools for cancer treatment, it has proven difficult to get them to tumor cells at therapeutic levels.

4 Dec 2014

Sanovas's endoscopic imaging platform recognized by Frost & Sullivan

Based on its recent analysis of the endoscopic imaging market, Frost & Sullivan recognizes Sanovas Inc. with the 2014 Global Frost & Sullivan Award for New Product Innovation Leadership. In a market where spiralling healthcare costs impact the entire spectrum of stakeholders, Sanovas's ground-breaking endoscopic platform, MicroCam, provides the functionality of a high-end, flexible endoscope without the accompanying cost and maintenance burden.

1 Dec 2014

BWH researchers identify two-faced role of TIM-3 protein

A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system -- sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.

26 Nov 2014

Microscope objectives for ultra-deep biological imaging introduced by Olympus

Two dedicated microscope objectives optimized for deep, high-resolution imaging of life science specimens up to 8mm beneath the surface have been introduced by Olympus.

From Evident Corporation - Life Sciences 13 Nov 2014

Rose Medical Center becomes first hospital in Colorado to perform new procedure for PAD patients

Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.

12 Nov 2014

Olympus to host fifth annual neuroimaging symposium in conjunction with 2014 annual meeting of the Society for Neuroscience

Olympus is hosting its fifth annual neuroimaging symposium in conjunction with the 2014 annual meeting of the Society for Neuroscience (SfN) on Monday, November 17 at 6:30pm in Washington DC. The Olympus Neuroimaging Symposium and reception will be held at the Marriott Marquis Washington, DC, 901 Massachusetts Avenue NW, in the Capitol and Congress ballrooms. It is open to all media and registered SfN attendees.

From Evident Corporation - Life Sciences 10 Nov 2014

Bowel Cancer UK emphasizes issues relating to diagnostic tests for bowel cancer

Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, “Diagnosing bowel cancer early: right test, right time,” highlights their concerns in more detail.

5 Nov 2014

Gefitinib drug boosts oesophageal cancer patients' survival by up to six months

Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Wednesday).

4 Nov 2014

EndoChoice study supports Fuse Full Spectrum Endoscopy System

EndoChoice announced the release of study data supporting the efficacy of the Fuse Full Spectrum Endoscopy System. These studies were presented simultaneously by leading gastroenterologists at the American College of Gastroenterology Annual Scientific Session in Philadelphia, PA, and the United European Gastroenterology Week in Vienna, Austria.

30 Oct 2014